(Q36467361)

14 August 2017

The size of clinical trials in cancer research--what are the current needs? Medical Research Council Cancer Therapy Committee (English)

1 reference

14 August 2017

Freedman LS

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 1989

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

59

1 reference

14 August 2017

3

1 reference

14 August 2017

396-400

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1989.79

14 August 2017

0 references

cites work

Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247078

Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247078

An efficient design for phase III studies of combination chemotherapies.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247078

Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247078

Endoscopic coagulation of upper gastrointestinal haemorrhage, one; randomised clinical trials, two.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247078

Why do we need systematic overviews of randomized trials?

28 June 2018

1 reference

12 December 2020

Theological interference in medicine

1 reference

12 December 2020

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

1 reference

12 December 2020

Amputation and Adriamycin in Primary Osteosarcoma

1 reference

12 December 2020

Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7)

1 reference

12 December 2020

Why do we need some large, simple randomized trials?

1 reference

12 December 2020

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1989.79

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

2930705

1 reference